Patient-Reported Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease
{{output}}
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease worldwide and can progress to serious complications, including metabolic dysfunction-associated steatohepatitis (MASH), cirrhosis, end-stage liver disease... ...
